Bodil Ivarsson

Dr. Bodil Ivarsson

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
BIBodil Ivarsson
Bodil Ivarsson
SLSylvia Larsson
Sylvia Larsson
CLCarsten Lührs
Carsten Lührs
TSTrygve Sjöberg
Trygve Sjöberg
It is important that patients for whom cardiac surgery is planned are supplied with structured oral and written information regarding their disease and its treatment, so that they can understand and discuss the coming operation and the risk of complications. The aim was to describe patients' experiences of information regarding possible complications related to cardiac surgery, both before and after the operation. A comparison was made between patients who received detailed written information (intervention group) regarding possible complications and patients who received conventional information (control group). One hundred eighty-two patients were included in the intervention group and 156 in the control group. Questionnaires were distributed and experiences, anxiety and depression (the Hospital Anxiety and Depression Scale, HADS), and avoidance or intrusion distress (the Impact of Event Scale, IES) were measured before and 8 weeks after the surgery. Seventy-two percent of the intervention group and 69% of the control group wanted information about both common and rare complications. Patients in the intervention group were significantly more satisfied with all aspects of the information compared to the control group both pre- and post-operatively. There were no significant differences between the groups for either the HADS or the IES. Most, but not all, patients in the present study were positive to the extended written detailed information about risk of complications in connection with cardiac surgery. Detailed information can be a useful base for fruitful conversations between the health care personnel and the patients. The patients and their next of kin are informed, and better prepared if complications occur.

22 October 2020 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
BKBarbro Kjellström
Barbro Kjellström
ASAnna Sandqvist
Anna Sandqvist
CHClara Hjalmarsson
Clara Hjalmarsson
MNMagnus Nisell
Magnus Nisell
PNPer Näsman
Per Näsman
BIBodil Ivarsson
Bodil Ivarsson
Background Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong treatment. The aim of the present study was to investigate adherence to disease specific treatment in patients with PAH or CTEPH. Methods The study comprised an adult population diagnosed with PAH (n=384) or CTEPH (n=187) alive in 2016–2017. The study utilised three registries; the Swedish PAH registry, the National Board of Health and Welfare and, Statistics Sweden. Withdrawals from pharmacies of disease-specific oral treatments were studied. Adherence was assessed as; 1) Number of days covered defined as the difference between the total number of daily dosages dispensed and the total number of days covered and 2) Manual assessment by two persons that independently reviewed each patient9s prescription fill history to detect anomalies or patterns of deteriorating or improving adherence over time. Results The mean age was 61±16 years, 61% were female and mean time since diagnosis was 4.6 years. Adherence was 62% using the Number of days covered method and 66% by the Manual assessment method. Drug specific adherence varied from 91% for riociguat to 60% for sildenafil. Good adherence was associated to shorter time since diagnosis in patients with PAH and to lower number of concomitant other chronic treatments in patients with CTEPH. Age, sex, socioeconomic status, or number of PH-treatments were not associated to adherence. Conclusion Adherence to oral disease specific treatment was 60–65% and associated to time since diagnosis and number of concomitant chronic treatments. Sex, age or socioeconomic factors did not affect adherence.

6 February 2017 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
SÅSusanna Ågren
Susanna Ågren
TSTrygve Sjöberg
Trygve Sjöberg
BEBjörn Ekmehag
Björn Ekmehag
MWMaj‐Britt Wiborg
Maj‐Britt Wiborg
BIBodil Ivarsson
Bodil Ivarsson

16 July 2018 in Chronic Respiratory Disease
Verified
Journal Article
Open access
PDF file
BIBodil Ivarsson
Bodil Ivarsson
RHRoger Hesselstrand
Roger Hesselstrand
GRGöran Rådegran
Göran Rådegran
BKBarbro Kjellström
Barbro Kjellström
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) share similar quality of life impairment. The aim of the present study was to investigate health-related quality of life (HRQoL) and its relation to the perception of treatment and psychosocial support among PAH and CTEPH patients. All adult PAH or CTEPH patients in the Swedish Pulmonary Arterial Hypertension Register were invited to participate in a national cohort survey. The survey included the EuroQol 5-dimensions (EQ-5D) instrument that measures an individual’s HRQoL; the Beliefs about Medicines Questionnaire-Specific Scale that assesses the perception of PAH-specific treatment; the Mastery scale that evaluates the feeling of control and ability to cope with the disease; and the Social Network and Support Scale that maps the social support network. Of the 440 invited patients, 74% responded. Mean age was 66 ± 14 years, 58% were female and 69% diagnosed with PAH. Patients with PAH were younger, more often female and had a lower EQ-5D index (0.67 ± 0.29 vs. 0.73 ± 0.25, p = 0.050) than patients with CTEPH. Patients with a low EQ-5D index had more concerns about treatment (p = 0.004), lower coping ability (p < 0.001), less emotional support (p = 0.003) and less accessible social network (p = 0.002). In conclusion, patients with an impaired HRQoL also reported negative effects on their social support network, ability to handle stressors and concerns about treatment.

26 November 2012 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
BIBodil Ivarsson
Bodil Ivarsson
BEBjörn Ekmehag
Björn Ekmehag
TSTrygve Sjöberg
Trygve Sjöberg
Background: Heart or lung recipients are taught about a new lifestyle, risk factors, medication, food restrictions and exercise so they can take an active role and responsibility for disease management after transplantation. However, little is known about patients’ experiences of information and support in these situations. Objective: The aim of the study was to illuminate how patients, six months after a heart or lung transplantation, experienced the information and support they received in connection with the transplantation. Methods: Sixteen patients were included in the study, and interviews were analysed using a qualitative content analysis method. Results: The findings are presented in three themes: Alternating between gratitude and satisfaction and resignation, Striving to follow treatment strategies and Returning to a relatively normal life. The patients expressed gratitude when their health improved markedly but resignation when complications or side effects occurred due to the lack of information and support they received. Conclusions: Healthcare professionals can make specific improvements in the information they provide to patients to increase their preparedness. Information and support should be provided regularly so as to avoid non-adherence to essential guidelines. To return to a normal life, patients need support from healthcare organizations, families, employers and society in general. These findings should be taken into account in the clinical management of transplant patients, particularly those with dependent children or failing social networks.

1 July 2019 in ERJ Open Research
Verified
Journal Article
Open access
BKBarbro Kjellström
Barbro Kjellström
MNMagnus Nisell
Magnus Nisell
DKDavid Kylhammar
David Kylhammar
SBSven-Erik Bartfay
Sven-Erik Bartfay
BIBodil Ivarsson
Bodil Ivarsson
CHClara Hjalmarsson
Clara Hjalmarsson
Background: Women with idiopathic pulmonary arterial hypertension (IPAH) have been found to have a worse haemodynamic status at diagnosis, but better survival than men. Over the past decade, demographics have changed and new treatments have become available. The objective of this study was to investigate sex differences in an incident IPAH population diagnosed between 2008 and 2016.Methods: Differences in clinical characteristics of patients included in the Swedish Pulmonary Arterial Hypertension Register (SPAHR) were analysed at the time of diagnosis. Survival by sex was investigated using Cox proportional hazard regression and Kaplan–Meier curves.Results: The study included 271 patients diagnosed with IPAH, median age was 68 (1st–3rd quartiles 54–74) years and 56% were women. At diagnosis, women were younger, had lower pulmonary vascular resistance and fewer comorbidities and more often received a combination of PAH-targeted therapies than men. Men had worse survival rates than women (hazard ratio 1.49; CI 1.02–2.18; p=0.038), but this difference did not remain after adjustment for age (hazard ratio 1.30; CI 0.89–1.90; p=0.178).Conclusions: Men with incident IPAH have worse crude survival than women. This is due to women being younger with a less pronounced comorbidity burden than men at the time of diagnosis.